Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Jean Jacques Lafitte"'
Autor:
Thierry Berghmans, Arnaud Scherpereel, Anne-Pascale Meert, Vicente Giner, Jacques Lecomte, Jean-Jacques Lafitte, Nathalie Leclercq, Marianne Paesmans, Jean-Paul Sculier, for the European Lung Cancer Working Party (ELCWP)
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
IntroductionIn a literature meta-analysis, we showed survival benefits for regimens including cisplatin [hazard ratio (HR) 0.61; 95% confidence interval (CI), 0.57–0.66] and for those including etoposide (HR 0.65; 0.61–0.69). That benefit was mai
Externí odkaz:
https://doaj.org/article/def77f8f82b74a1db40ee3da9b8c1674
Autor:
Thierry Berghmans, Jean-Jacques Lafitte, Arnaud Scherpereel, Lieveke Ameye, Marianne Paesmans, Anne-Pascale Meert, Benoit Colinet, Christian Tulippe, Luc Willems, Nathalie Leclercq, Jean-Paul Sculier, for the European Lung Cancer Working Party
Publikováno v:
ERJ Open Research, Vol 1, Iss 2 (2015)
Salvage chemotherapy (CT) for relapsing or refractory small cell lung cancer (SCLC) remains disappointing. In vitro experiments showed that valproic acid increases apoptosis of SCLC cell lines exposed to doxorubicin, vindesine and bis(2-chloroethyl)a
Externí odkaz:
https://doaj.org/article/bb22aba710104b5682bec48263f17450
Autor:
Michelle Coureau, Georgiana Bentea, Anne-Pascale Meert, Lucien Ruelle, Bogdan Grigoriu, Julie Gorham, Jean-Paul Sculier, Valérie Durieux, Jean-Jacques Lafitte, Spyridon Sideris, Thierry Berghmans, Stéphane Holbrechts, Claudine Sculier
Publikováno v:
Lung Cancer. 111:164-175
The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6532bf7a2e353a51980396845c5d62ab
https://doi.org/10.1016/j.lungcan.2017.07.026
https://doi.org/10.1016/j.lungcan.2017.07.026
Autor:
Luigi Moretti, Anne-Pascale Meert, Nicolas Girard, Jean-Jacques Lafitte, Christiane Jungels, Valérie Durieux, Martine Roelandts, Thierry Berghmans, Stéphane Holbrechts, Sebahat Ocak
Publikováno v:
Lung cancer, Vol. 126, p. 25-31 (2018)
Thymic tumours are rare diseases that for most of the cases are cured with surgery and eventually adjuvant radiotherapy. However, about 30% of patients present with advanced stage or relapsing tumours, which require administration of chemotherapy. Wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff8b4447e4ba813e9f746a0510da31d4
https://hdl.handle.net/2078.1/208839
https://hdl.handle.net/2078.1/208839
Autor:
Muhammad Siddique, Connie Yip, David Landau, Jacques Remy, Vicky Goh, Paul Bassett, Frederic Wallyn, Arnaud Scherpereel, Gary Cook, Martine Remy-Jardin, Nunzia Tacelli, Alexis B. Cortot, Jean-Jacques Lafitte
Publikováno v:
Journal of Thoracic Imaging. 30:300-307
Purpose We aimed to assess computed tomography (CT) intratumoral heterogeneity changes, and compared the prognostic ability of the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1, an alternate response method (Crabb), and CT heterogeneity i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6329ea190e2fc934fb6c0050a5916a74
https://doi.org/10.1097/rti.0000000000000164
https://doi.org/10.1097/rti.0000000000000164
Autor:
Bogdan Grigoriu, Stéphane Holbrechts, Lucien Ruelle, Anne-Pascale Meert, Georgiana Bentea, Spyridon Sideris, Mohamed El Koulali, Thierry Berghmans, Claudine Sculier, Valérie Durieux, Jean-Paul Sculier, Jean-Jacques Lafitte
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 111
The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ac6a81462be66d7a9313b847076ff4d
https://pubmed.ncbi.nlm.nih.gov/28838388
https://pubmed.ncbi.nlm.nih.gov/28838388
Autor:
Anne-Pascale Meert, Martine Roelandts, Stéphane Holbrechts, Jean-Jacques Lafitte, Sebahat Ocak, Thierry Berghmans, Alain Van Meerhaeghe, Luigi Moretti, Françoise Pasleau, Lieveke Ameye, Marianne Paesmans, Bogdan Grigoriu, Sophie Danyi, Jean-Paul Sculier
Publikováno v:
European Respiratory Journal. 45:511-524
The use of noninferiority randomised trials for patients with advanced non-small cell lung cancer has emerged during the past 10–15 years but has raised some issues related to their justification and methodology. The present systematic review aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da7894cfdca2225f0bec5fb4c7ce4f27
https://doi.org/10.1183/09031936.00092814
https://doi.org/10.1183/09031936.00092814
Autor:
Marie Wislez, J.-P. Gury, P. Foucher, O. Raffy, E. Devin, François Goupil, P.J. Souquet, Jean-Jacques Lafitte, Franck Morin, D. Braun, Philippe Girard, Jean Trédaniel, E. Pichon, J. Domas, Elisabeth Quoix, P. Dumont, M. Derollez, J. Hermann, Virginie Westeel, Fabrice Barlesi
Publikováno v:
Revue des Maladies Respiratoires. 35:A17-A18
Introduction Plusieurs recommandations proposent une surveillance reguliere clinique et scanographique thoracique apres chirurgie d’un CBNPC. En l’absence de donnees issues d’essais randomises publies, ces recommandations correspondent plutot a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0bdeab9fff208433c8ebd2d27671d36
https://doi.org/10.1016/j.rmr.2017.10.038
https://doi.org/10.1016/j.rmr.2017.10.038
Autor:
Arnaud Scherpereel, Thierry Berghmans, Alexis B. Cortot, Céline Mascaux, Jean-Paul Sculier, Ingrid CsToth, Lieveke Ameye, Marianne Paesmans, Luc Willems, Anne-Pascale Meert, L Toussaint, Nathalie Leclercq, Tiffany Dernies, Jean-Jacques Lafitte
Publikováno v:
Lung Cancer. 82:340-345
Clinical variables, like stage and performance status (PS), have predictive and prognostic values in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy, not allowing adequate individual prediction. MicroRNA (miRNA) are non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a65fea0788154afb3769d5e97870e99
https://doi.org/10.1016/j.lungcan.2013.07.020
https://doi.org/10.1016/j.lungcan.2013.07.020
Autor:
Jean-Jacques Lafitte, Gregory Petyt, Stefanie Habib, Julie Delourme, Alexis B. Cortot, Nunzia Tacelli, Arnaud Scherpereel, Xavier Dhalluin
Publikováno v:
Lung Cancer. 80:197-202
Background Combination of bevacizumab and weekly paclitaxel showed synergitic effects, anti-tumor efficacy and a good toxicity profile for patients with breast cancer but has never been evaluated in non small cell lung cancer (NSCLC). We retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::360ce4fc47a62c3e303e2d728a95b393
https://doi.org/10.1016/j.lungcan.2013.01.015
https://doi.org/10.1016/j.lungcan.2013.01.015